Fig. 3From: Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort studyKaplan Meier hazard function of DR-TB patients with major adverse drug event on second line anti-TB drugs in Amhara Regional State Public Hospitals from September 2010 –Dec ember 2017Back to article page